Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head-and-neck cancer.
about
Planned neck dissection following chemo-radiotherapy in advanced HNSCCSalvage surgery in post-chemoradiation laryngeal and hypopharyngeal carcinoma: outcome and reviewThe clinical importance of assessing tumor hypoxia: relationship of tumor hypoxia to prognosis and therapeutic opportunitiesThe role of neck dissection in squamous cell carcinoma of the head and neck.Split course hyperfractionated accelerated radio-chemotherapy (SCHARC) for patients with advanced head and neck cancer: influence of protocol deviations and hemoglobin on overall survival, a retrospective analysisDiffusion-weighted magnetic resonance imaging in neck lymph adenopathy.Pilot Study of 99mTc-labeled Ethylene Dicysteine Deoxyglucose SPECT-CT Imaging in Treatment Response Evaluation in Patients with Locally Advanced Head and Neck Cancer.Clinical biomarkers for hypoxia targetingAdvances in the management of squamous cell carcinoma of the head and neck.Prediction of concurrent chemoradiotherapy outcome in advanced oropharyngeal cancer.Prediction of neck dissection requirement after definitive radiotherapy for head-and-neck squamous cell carcinomaReliability of post-chemoradiotherapy F-18-FDG PET/CT for prediction of locoregional failure in human papillomavirus-associated oropharyngeal cancerLong-term regional control in the observed neck following definitive chemoradiation for node-positive oropharyngeal squamous cell cancer.Hyperfractionated radiotherapy with concurrent cisplatin/5-Fluorouracil for locoregional advanced head and neck cancer: analysis of 105 consecutive patients.Long-term outcome and toxicity of hypofractionated stereotactic body radiotherapy as a boost treatment for head and neck cancer: the importance of boost volume assessment.Swallowing function following postchemoradiotherapy neck dissection: review of findings and analysis of contributing factors.Assessment of outcomes with delayed (18)F-FDG PET-CT response assessment in head and neck squamous cell carcinoma.New developments in radiation therapy for head and neck cancer: intensity-modulated radiation therapy and hypoxia targeting.Treatment of advanced neck metastases.Retrospective review of positron emission tomography with contrast-enhanced computed tomography in the posttreatment setting in human papillomavirus-associated oropharyngeal carcinomaViable tumor in postchemoradiation neck dissection specimens as an indicator of poor outcomeEarly detection of recurrent disease by FDG-PET/CT leads to management changes in patients with squamous cell cancer of the head and neck.Up-front neck dissection followed by concurrent chemoradiation in patients with regionally advanced head and neck cancer.Selective versus comprehensive neck dissection after chemoradiation for advanced oropharyngeal squamous cell carcinoma.The emerging era of personalized therapy in squamous cell carcinoma of the head and neck.Persistent neck disease after chemoradiation for head and neck squamous cell carcinoma.Planned neck dissection following radiation treatment for head and neck malignancy.The role of neck dissection after radical chemoradiation for locally advanced head and neck cancer: should we move back?.Efficacy of neck dissection in the management of isolated nodal recurrence after head and neck cancer treatment.Observation versus neck dissection for positron-emission tomography-negative lymphadenopathy after chemoradiotherapy.Management of the neck in node-positive tonsillar cancer.Sentinel lymph node - work hypothesis in sinonasal carcinoma treatment.Multiparametric imaging using 18F-FDG PET/CT heterogeneity parameters and functional MRI techniques: prognostic significance in patients with primary advanced oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiotherapy.Planned neck dissection following primary chemoradiation for advanced-stage head and neck cancer.The role of CT and ¹⁸F-FDG PET in managing the neck in node-positive head and neck cancer after chemoradiotherapy.Role and extent of neck dissection for persistent nodal disease following chemo-radiotherapy for locally advanced head and neck cancer: how much is enough?Preliminary results of pre-radiation neck dissection in head and neck cancer patients undergoing organ preservation treatment.[Follow-up ultrasound of head and neck cancer].Imaging strategy for response evaluation to chemoradiotherapy of the nodal disease in patients with head and neck squamous cell carcinoma.Predictive markers, including total lesion glycolysis, for the response of lymph node(s) metastasis from head and neck squamous cell carcinoma treated by chemoradiotherapy.
P2860
Q24796568-F762375A-D0E4-4554-A9B0-593C55E4CC19Q26798275-9AE20F17-A81A-4796-89ED-04B0733F6B5BQ27025579-CE04F0AA-C12E-407D-B864-7FF88412D0BEQ30366869-0EC5C69A-D066-477B-98E9-935BB5695E6EQ33265638-B4BEADB0-A73D-43CC-A58C-6FA7A670E594Q33372678-188345FD-3F5B-48A3-8228-4423B46A3386Q33664572-8498FC70-028E-4CA9-A18E-47E1A93A7F80Q33714638-A558DE6C-01B8-4EC3-91B4-86AA277A878DQ33720431-E0EE943C-3B2E-4C10-ACE6-CE2468701F32Q34000625-4D171F9A-10AB-48E1-BF8F-29CD51558978Q34015012-A9B605C5-B68A-416B-8E50-447C5EDD54A8Q34156288-2065D301-1872-4732-AF60-C166DFF7E2D7Q36060737-9E3118C0-987C-471C-A029-FA5647B5E076Q36072454-C27D17BA-C6E4-453D-8AE0-57968B913489Q36143371-7CAE01A9-A5A6-4F24-ACC8-1BF6E4CAE93EQ36210759-281EC01F-92CF-4294-A78B-B2C00E3E93C5Q36295724-6FF44967-C987-48E8-A1FF-A40B67192428Q36807138-802FF9A8-3A22-4B26-8582-20D8EE938722Q36882890-EB9A2DA0-6017-439A-9955-BF0BA7F1EAC3Q37023751-D79B9DF7-CBC8-4A23-8017-D5CD5EAB7EE0Q37170012-A70380E9-DBB9-444A-98F3-E78299E78E4AQ37247189-58417CC2-CE9A-4828-A8E7-41FF14298A83Q37408357-008F9AE6-0338-4CFA-B09B-95EAF4C6124AQ37637292-8270FC12-7F90-43AA-87E6-760E35766653Q37925133-4FCD9106-862F-440F-B060-84167FC49192Q38044548-3FDCA725-6AA8-442A-BFE2-8C12B1E072EEQ38050765-45D85C25-4581-4A9B-9A3A-BC5D2D93113AQ38073089-EBA42496-A353-4DE4-9DED-EAC58D8513CDQ38073681-5C678B89-BCCF-4473-9182-0AB9C4DC8FA8Q38151625-1E209BBB-31AB-403F-8F1D-A8BCBBA048F1Q41739742-A75F5776-CDBC-49A2-93B0-2C07454DA3D5Q42229200-C9EF6EF7-26A7-4986-B6F2-D198F78D50CAQ42365356-D512E8C9-08DB-474F-9B56-F8C703DB2343Q43270117-29C0A717-1CF6-4BC4-9EC8-004541F445C2Q46328387-2B12EC2D-B985-4BC3-9B95-77BBC85CA681Q46734257-5ACF3E79-4816-4C25-B63C-900435EDB623Q46991053-893DFFA3-0BC4-4EBE-B80D-557A3C2BE667Q50110251-F6788E3E-1C9F-449D-B76A-FC07AAB0C962Q50898009-5B038314-6A64-4AFA-B0BE-1D279DEE9AADQ52924821-09E1D43A-9CCE-4613-9188-056585CD81E3
P2860
Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head-and-neck cancer.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Necessity for adjuvant neck di ...... advanced head-and-neck cancer.
@en
Necessity for adjuvant neck di ...... advanced head-and-neck cancer.
@nl
type
label
Necessity for adjuvant neck di ...... advanced head-and-neck cancer.
@en
Necessity for adjuvant neck di ...... advanced head-and-neck cancer.
@nl
prefLabel
Necessity for adjuvant neck di ...... advanced head-and-neck cancer.
@en
Necessity for adjuvant neck di ...... advanced head-and-neck cancer.
@nl
P2093
P1476
Necessity for adjuvant neck di ...... advanced head-and-neck cancer.
@en
P2093
David M Brizel
Mary Ann Downey
Richard L Scher
Robert G Prosnitz
Robert L Clough
Samuel R Fisher
Shannon Hunter
P304
P356
10.1016/J.IJROBP.2003.09.004
P407
P577
2004-04-01T00:00:00Z